Camber Capital Management
Latest statistics and disclosures from Camber Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are HCA HOLDINGS, TEVA, UHS, BSX, MYL. These five stock positions account for 30.20% of Camber Capital Management's total stock portfolio.
- Added to shares of HCA HOLDINGS (+$66.50M), WLP (+$40.61M), XLV (+$40.12M), CFN (+$28.39M), ALR (+$25.34M), ACOR (+$24.02M), WMGI (+$22.11M), SYK (+$20.87M), ARTC (+$20.57M), HOLX (+$20.24M).
- Started new stock positions in HOLX, HMA, DSCI, GNMK, BEAT, CFN, WLP, XLV, Sagent Pharmaceuticals, ALNY, CERN, ALR, ABC, ANGO, WMGI, CNMD, ACOR, DNDN, SYK, MRX, ARTC, UNH, MNTA.
- Reduced shares in these stocks: CFN (-$38.90M), HCA HOLDINGS (-$37.11M), TEVA (-$36.03M), WMGI (-$28.30M), ACOR (-$26.55M), CPTS (-$23.60M), WAG (-$21.77M), ALR (-$20.81M), SQNM (-$20.35M), AUXL (-$20.23M).
- Sold out of its positions in ACOR, ALR, ALTH, ALNY, AUXL, BEAT, CFN, DVAX, ELN, HCA HOLDINGS, HTWR, LPNT, SQNM, THC, VPHM, WAG, WHRT, WMGI, ZMH, Warner Chilcott Plc -.
- As of Sept. 30, 2012, Camber Capital Management has $839.30M in assets under management (AUM). Assets under management grew from a total value of $739.81M to $839.30M.
- Independent of market fluctuations, Camber Capital Management was a net buyer by $67.71M worth of stocks in the most recent quarter.
Camber Capital Management portfolio companies for quarter ending September 2012
| Ticker | Name | Portfolio Weight | Change | Share Count | Price | Last Trade |
|---|---|---|---|---|---|---|
| HCA HOLDINGS | 7.92 | NEW | 2000000 | 33.25 | 0.00 | |
| TEVA | Teva Pharmaceutical Industries | 6.07 | -41.00% | 1230000 | 41.41 | 40.23 |
| UHS | Universal Health Services | 5.99 | +57.00% | 1099200 | 45.73 | 67.04 |
| BSX | Boston Scientific Corporation | 5.13 | +15.00% | 7500000 | 5.74 | 9.10 |
| MYL | Mylan | 5.09 | +16.00% | 1750000 | 24.40 | 31.40 |
| WLP | WellPoint | 4.84 | NEW | 700000 | 58.01 | 77.81 |
| XLV | Health Care SPDR | 4.78 | NEW | 1000000 | 40.12 | 49.10 |
| Vanguard Health Systems | 4.60 | +14.00% | 3118468 | 12.37 | 0.00 | |
| CFN | CareFusion Corporation | 3.38 | NEW | 1000000 | 28.39 | 34.36 |
| FRX | Forest Laboratories | 3.18 | -25.00% | 750000 | 35.61 | 38.53 |
| ALR | Alere | 3.02 | NEW | 1300000 | 19.49 | 26.30 |
| ACOR | Acorda Therapeutics | 2.86 | NEW | 938000 | 25.61 | 32.94 |
| WMGI | Wright Medical | 2.63 | NEW | 1000000 | 22.11 | 24.64 |
| BABY | Natus Medical | 2.57 | -11.00% | 1650000 | 13.07 | 14.36 |
| MASI | Masimo Corporation | 2.54 | -11.00% | 880200 | 24.18 | 22.23 |
| SYK | Stryker Corporation | 2.49 | NEW | 375000 | 55.66 | 68.90 |
| ARTC | ArthroCare Corporation | 2.45 | NEW | 635000 | 32.40 | 34.65 |
| HOLX | Hologic | 2.41 | NEW | 1000000 | 20.24 | 21.09 |
| KND | Kindred Healthcare | 2.35 | +332.00% | 1730000 | 11.38 | 12.16 |
| ALNY | Alnylam Pharmaceuticals | 2.24 | NEW | 1000000 | 18.79 | 27.44 |
| MRX | Medicis Pharmaceutical Corporation | 2.06 | NEW | 400000 | 43.27 | 0.00 |
| ABC | AmerisourceBergen | 1.91 | NEW | 415000 | 38.71 | 54.99 |
| LLY | Eli Lilly & Co. | 1.86 | -52.00% | 330000 | 47.41 | 55.90 |
| DNDN | Dendreon Corporation | 1.64 | NEW | 2850000 | 4.83 | 4.01 |
| GILD | Gilead Sciences | 1.58 | -60.00% | 200000 | 66.33 | 56.30 |
| HMA | Health Management Associates | 1.50 | NEW | 1500000 | 8.39 | 10.71 |
| CPTS | Conceptus | 1.45 | -65.00% | 600000 | 20.31 | 30.92 |
| UNH | UnitedHealth | 1.32 | NEW | 200000 | 55.41 | 62.84 |
| DSCI | Derma Sciences | 1.30 | NEW | 1050000 | 10.38 | 14.29 |
| MNTA | Momenta Pharmaceuticals | 1.04 | NEW | 600000 | 14.57 | 13.03 |
| GNMK | GenMark Diagnostics | 1.04 | NEW | 950000 | 9.21 | 15.20 |
| ANGO | AngioDynamics | 0.95 | NEW | 653200 | 12.20 | 10.68 |
| CERN | Cerner Corporation | 0.92 | NEW | 100000 | 77.39 | 98.83 |
| CCRN | Cross Country Healthcare | 0.79 | 1399792 | 4.73 | 5.26 | |
| Sagent Pharmaceuticals | 0.76 | NEW | 400000 | 15.95 | 0.00 | |
| BEAT | Cardionet | 0.75 | NEW | 2481412 | 2.52 | 2.77 |
| MDCO | Medicines Company | 0.62 | -53.00% | 200000 | 25.81 | 35.76 |
| CNMD | CONMED Corporation | 0.58 | NEW | 170200 | 28.50 | 33.44 |
| Anthera Pharmaceuticals | 0.37 | NEW | 3100000 | 0.99 | 0.00 | |
| RAD | Rite Aid Corporation | 0.35 | -50.00% | 2500000 | 1.17 | 2.79 |
| DRRX | DURECT Corporation | 0.33 | +30.00% | 1950000 | 1.44 | 0.89 |
| Celgene Corp right 12/31/2011 | 0.32 | 949358 | 2.82 | 0.00 | ||
| Anthera Pharmaceuticals | 0.03 | 400000 | 0.55 | 0.00 |
Past 13F-HR SEC Filings for Camber Capital Management
- Camber Capital Management 2012 Q1 - filed May 15, 2012
- Camber Capital Management 2011 Q4 - filed Feb. 14, 2012
- Camber Capital Management 2011 Q3 - filed Nov. 14, 2011
- Camber Capital Management 2011 Q2 - filed Aug. 15, 2011
- Camber Capital Management 2011 Q1 - filed May 16, 2011
- Camber Capital Management 2010 Q4 - filed Feb. 14, 2011